Mайкролакс

Sorbitol, Sodium Citrate and Sodium Lauryl Sulfoacetate, the active ingredients in Mайкролакс, are laxatives presented as a rectal solution for adult use. They are intended to relieve occasional constipation by softening stool and promoting evacuation.

GNH USA supplies Mайкролакс as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU quality standards and is manufactured under GMP conditions. It is distributed through a regulated supply chain ensuring product integrity and traceability. Customers benefit from dedicated technical support and documentation for regulatory submissions.

Mайкролакс is a rectally administered laxative that acts on the lower gastrointestinal tract to alleviate constipation. - Constipation: softens stool and stimulates rectal evacuation, providing relief of infrequent bowel movements. - Bowel preparation: assists in clearing the colon before diagnostic procedures such as colonoscopy. - Occasional constipation in adults: offers rapid, over‑the‑counter relief without systemic absorption.

Mайкролакс may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramping: mild discomfort in the lower abdomen. - Flatulence: increased intestinal gas. - Mild diarrhea: loose stools occurring shortly after use. - Rectal irritation: transient burning or itching at the application site. - Nausea: occasional feeling of queasiness. - Urgency to defecate: sudden need to pass stool.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal blood sodium or potassium levels. - Allergic reaction: rash, swelling, or difficulty breathing. - Severe abdominal pain: intense, persistent pain requiring medical attention. - Rectal bleeding: presence of blood in stool or on toilet paper. - Dehydration: excessive fluid loss leading to dizziness or weakness.

Before using Mайкролакс, consider the following precautions to ensure safe and effective use. - Assess severity of constipation: confirm that symptoms are mild to moderate and suitable for an over‑the‑counter laxative. - Avoid in intestinal obstruction: do not use if there is known blockage or severe abdominal pain. - Use cautiously with inflammatory bowel disease: patients with Crohn’s disease or ulcerative colitis should consult a healthcare professional. - Do not exceed recommended frequency: limit applications to the dosage instructions provided by the prescriber. - Monitor fluid intake: maintain adequate hydration to reduce risk of dehydration. - Store at ambient temperature: keep the product in its original container, protect from moisture and direct sunlight.

Mайкролакс can interact with other medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent osmotic laxatives: combined use may cause severe electrolyte disturbances. - Anticholinergic agents: may reduce the laxative effect and increase constipation risk. - Dehydrating medications: such as diuretics, can amplify fluid loss.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolyte balance and hydration status. - Mineral supplements (calcium, magnesium): may alter stool consistency. - Oral anticoagulants: rare risk of increased rectal bleeding; observe for signs of bleeding.